Adult Urology Oncology : Adrenal / Renal / Upper Tract / Bladder A Genomic Algorithm for the Molecular Classification of Common Renal Cortical Neoplasms : Development and Validation

PURPOSE Accurate discrimination of benign oncocytoma and malignant renal cell carcinoma is useful for planning appropriate treatment strategies for patients with renal masses. Classification of renal neoplasms solely based on histopathology can be challenging, especially the distinction between chromophobe renal cell carcinoma and oncocytoma. In this study we develop and validate an algorithm based on genomic alterations for the classification of common renal neoplasms. MATERIALS AND METHODS Using TCGA renal cell carcinoma copy number profiles and the published literature, a classification algorithm was developed and scoring criteria were established for the presence of each genomic marker. As validation, 191 surgically resected formalin fixed paraffin embedded renal neoplasms were blindly submitted to targeted array comparative genomic hybridization and classified according to the algorithm. CCND1 rearrangement was assessed by fluorescence in situ hybridization. RESULTS The optimal classification algorithm comprised 15 genomic markers, and involved loss of VHL, 3p21 and 8p, and chromosomes 1, 2, 6, 10 and 17, and gain of 5qter, 16p, 17q and 20q, and chromosomes 3, 7 and 12. On histological rereview (leading to the exclusion of 3 specimens) and using histology as the gold standard, 58 of 62 (93%) clear cell, 51 of 56 (91%) papillary and 33 of 34 (97%) chromophobe renal cell carcinomas were classified correctly. Of the 36 oncocytoma specimens 33 were classified as oncocytoma (17 by array comparative genomic hybridization and 10 by array comparative genomic hybridization plus fluorescence in situ hybridization) or benign (6). Overall 93% diagnostic sensitivity and 97% specificity were achieved. CONCLUSIONS In a clinical diagnostic setting the implementation of genome based molecular classification could serve as an ancillary assay to assist in the histological classification of common renal neoplasms.

[1]  Antonio Lopez-Beltran,et al.  2004 WHO classification of the renal tumors of the adults. , 2006, European urology.

[2]  Ximing J. Yang,et al.  Robust Classification of Renal Cell Carcinoma Based on Gene Expression Data and Predicted Cytogenetic Profiles , 2004, Cancer Research.

[3]  Ming Zhou,et al.  Renal mass sampling: An enlightened perspective , 2011, International journal of urology : official journal of the Japanese Urological Association.

[4]  F. Guillé,et al.  Unclassified renal cell carcinoma: an analysis of 85 cases , 2007, BJU international.

[5]  D. Warburton,et al.  Renal oncocytomas with rearrangements involving 11q13 contain breakpoints near CCND1. , 2004, Cancer genetics and cytogenetics.

[6]  Amnon Zisman,et al.  Cytogenetic and Molecular Tumor Profiling for Type 1 and Type 2 Papillary Renal Cell Carcinoma , 2009, Clinical Cancer Research.

[7]  P. Pierorazio,et al.  Active Surveillance for Small Renal Masses. , 2020, Reviews in urology.

[8]  F. Waldman,et al.  Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. , 1996, Cancer research.

[9]  Bihong T. Chen,et al.  Nonparotid parapharyngeal oncocytoma: A case report and literature review , 2009, Head & neck.

[10]  M. Paterson,et al.  FISH analysis in chromophobe renal‐cell carcinoma , 2000, Diagnostic cytopathology.

[11]  M. Tűrk,et al.  Cytotoxicity and apoptotic effects of nickel oxide nanoparticles in cultured HeLa cells. , 2011, Folia histochemica et cytobiologica.

[12]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.

[13]  H. Aburatani,et al.  Papillary Renal Cell Carcinoma: Quantitation of Chromosomes 7 and 17 by FISH, Analysis of Chromosome 3p for LOH, and DNA Ploidy , 1996, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[14]  Jorge Oliveira,et al.  Feasibility of differential diagnosis of kidney tumors by comparative genomic hybridization of fine needle aspiration biopsies , 2010, Genes, chromosomes & cancer.

[15]  H. Moch,et al.  Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes. , 1998, The American journal of pathology.

[16]  Jill M Hagenkord,et al.  Clinical genomics of renal epithelial tumors. , 2011, Cancer genetics.

[17]  K. Junker,et al.  Identification of tumor entities of renal cell carcinoma using interphase fluorescence in situ hybridization. , 2005, The Journal of urology.

[18]  G. La Manna,et al.  Small renal masses initially managed using active surveillance: results from a retrospective study with long-term follow-up. , 2014, Clinical genitourinary cancer.

[19]  W. Kaelin,et al.  A phase I study of cabozantinib (XL184) in patients with renal cell cancer. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  Gurpreet W. Tang,et al.  Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes , 2009, Nature.

[21]  Novel microRNA-based assay demonstrates 92% agreement with diagnosis based on clinicopathologic and management data in a cohort of patients with carcinoma of unknown primary , 2013, Molecular Cancer.

[22]  D. Barocas,et al.  Renal cell carcinoma sub‐typing by histopathology and fluorescence in situ hybridization on a needle‐biopsy specimen , 2007, BJU international.

[23]  R. Uzzo,et al.  Active surveillance of small renal masses , 2013, Nature Reviews Urology.

[24]  Ajay N. Jain,et al.  Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer. , 2002, Cancer research.

[25]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.

[26]  B Cochand-Priollet,et al.  Profiling and classification tree applied to renal epithelial tumours , 2007, Histopathology.

[27]  G. Kovacs,et al.  Lack of KISS1R expression is associated with rapid progression of conventional renal cell carcinomas , 2011, The Journal of pathology.

[28]  D. Reutzel,et al.  Genomic imbalances in 61 renal cancers from the proximal tubulus detected by comparative genomic hybridization , 2001, Cytogenetic and Genome Research.

[29]  P. Tamboli,et al.  Pathology and Chinese a Nti鄄 Cancer a Ssociation Diagnosis and Classification of Rcc , 2022 .

[30]  A. Bernheim,et al.  Characterization of quantitative chromosomal abnormalities in renal cell carcinomas by interphase four-color fluorescence in situ hybridization. , 2005, Cancer genetics and cytogenetics.

[31]  J. Cheville,et al.  CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma. , 2009, Human pathology.

[32]  V. Reuter,et al.  Subtyping of renal cortical neoplasms in fine needle aspiration biopsies using a decision tree based on genomic alterations detected by fluorescence in situ hybridization , 2014, BJU international.